Immune Responsiveness to Mycobacterium Leprae and Other Mycobacterial Antigens Throughout the Clinical and Histopathological Spectrum of Leprosy

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1973 Aug 1

PMID 4583777

Citations 72

Authors

B Myrvang

T Godal

D S RIDLEY

S S Froland

Y K Song

Affiliations

Soon will be listed here.

Citing Articles

New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells.

Negera E, Bobosha K, Walker S, Endale B, Howe R, Aseffa A Front Immunol. 2017; 8:1149.

PMID: 28966621 PMC: 5605646. DOI: 10.3389/fimmu.2017.01149.

Differential cytokine gene expression profiles in the three pathological forms of sheep paratuberculosis.

Smeed J, Watkins C, Rhind S, Hopkins J BMC Vet Res. 2007; 3:18.

PMID: 17697353 PMC: 1994670. DOI: 10.1186/1746-6148-3-18.

Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.

Hussain R, Shahid F, Zafar S, Dojki M, Dockrell H Immunology. 2004; 111(4):462-71.

PMID: 15056384 PMC: 1782444. DOI: 10.1111/j.0019-2805.2004.01839.x.

Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.

Hussain R, Kifayet A, Dojki M, Dockrell H Immunology. 1999; 98(2):238-43.

PMID: 10540222 PMC: 2326927. DOI: 10.1046/j.1365-2567.1999.00876.x.

Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy.

Hussain R, Dockrell H, Chiang T Immunology. 1999; 96(4):620-7.

PMID: 10233750 PMC: 2326793. DOI: 10.1046/j.1365-2567.1999.00740.x.

References

RIDLEY D, Jopling W . Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966; 34(3):255-73. View

Soborg M, BENDIXEN G . Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967; 181(2):247-56. DOI: 10.1111/j.0954-6820.1967.tb07255.x. View

Rees R, Waters M, WEDDELL A, Palmer E . Experimental lepromatous leprosy. Nature. 1967; 215(5101):599-602. DOI: 10.1038/215599a0. View

Lerner R, Glassock R, Dixon F . The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967; 126(6):989-1004. PMC: 2138413. DOI: 10.1084/jem.126.6.989. View

Soborg M . In vitro detection of cellular hypersensitivity in man. Specific migration inhibition of white blood cells from brucella-positive persons. Acta Med Scand. 1967; 182(2):167-74. View

Milde E, TONDER O . Demonstration of rheumatoid factor in tissue by mixed agglutination with tissue sections. Arthritis Rheum. 1968; 11(4):537-45. DOI: 10.1002/art.1780110403. View

Gaugas J . Enhancing effect of antilymphocytic globulin on human leprosy infection in thymectomized mice. Nature. 1968; 220(5173):1246-8. DOI: 10.1038/2201246a0. View

Mackaness G . The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969; 129(5):973-92. PMC: 2138649. DOI: 10.1084/jem.129.5.973. View

Rees R, WEDDELL A, Palmer E, Pearson J . Human leprosy in normal mice. Br Med J. 1969; 3(5664):216-7. PMC: 1984023. DOI: 10.1136/bmj.3.5664.216. View

10.

RIDLEY D, Waters M . Significance of variations within the lepromatous group. Lepr Rev. 1969; 40(3):143-52. DOI: 10.5935/0305-7518.19690026. View

11.

Chaparas S, Thor D, Godfrey H, Baer H, Hedrick S . Tuberculin-active carbohydrate that induces inhibition of macrophage migration but not lymphocyte transformation. Science. 1970; 170(3958):637-9. DOI: 10.1126/science.170.3958.637. View

12.

Froland S, Natvig J . Effect of polyspecific rabbit anti-immunoglobulin antisera on human lymphocytes in vitro. Int Arch Allergy Appl Immunol. 1970; 39(2-3):121-32. DOI: 10.1159/000230341. View

13.

Bullock Jr W, FASAL P . Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol. 1971; 106(4):888-99. View

14.

Godal T, Rees R, LAMVIK J . Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines. Clin Exp Immunol. 1971; 8(4):625-37. PMC: 1712963. View

15.

Turk J, Waters M . Immunological significance of changes in lymph nodes across the leprosy spectrum. Clin Exp Immunol. 1971; 8(3):363-76. PMC: 1712922. View

16.

Federlin K, Maini R, Russell A, Dumonde D . A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol. 1971; 24(6):533-6. PMC: 477088. DOI: 10.1136/jcp.24.6.533. View

17.

Turk J, Bryceson A . Immunological phenomena in leprosy and related diseases. Adv Immunol. 1971; 13:209-66. DOI: 10.1016/s0065-2776(08)60185-6. View

18.

Godal T, MYKLESTAD B, Samuel D, Myrvang B . Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Clin Exp Immunol. 1971; 9(6):821-31. PMC: 1713129. View

19.

Lane F, UNANUE E . Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med. 1972; 135(5):1104-12. PMC: 2138983. DOI: 10.1084/jem.135.5.1104. View

20.

Jondal M, Holm G, Wigzell H . Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972; 136(2):207-15. PMC: 2139198. DOI: 10.1084/jem.136.2.207. View